XML 69 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Revenues:      
Revenues $ 48,835 $ 20,653 $ 25,186
Expenses      
Cost of products sold 3,726 1,142
Research and development 107,068 84,888 66,962
Selling, general and administrative 37,121 29,514 13,933
Royalty 375 471 560
Total operating expenses 148,290 114,873 82,597
Loss from operations (99,455) (94,220) (57,411)
Interest and other income 1,933 2,252 1,015
Interest expense (11,892) (9,176) (8,565)
Gain (loss) on foreign currency derivative 517 (108) (821)
Net loss (108,897) (101,252) (65,782)
Unrealized gain (loss) on available for sale investments 336 (54) (231)
Net comprehensive loss $ (108,561) $ (101,306) $ (66,013)
Basic and diluted net loss per common share (in dollars per share) $ (0.94) $ (0.98) $ (0.78)
Weighted average shares outstanding (in shares) 115,600 103,185 84,451
Product [Member]      
Revenues:      
Revenues $ 17,533 $ 1,501
Royalty [Member]      
Revenues:      
Revenues 6,303 6,101 10,543
Collaborative and Other Research and Development [Member]      
Revenues:      
Revenues $ 24,999 $ 14,552 $ 13,142